Test Details: Moxifloxacin is a fluoroquinolone that has potent in vitro activity against M. tuberculosis. It is used in TB through early-phase clinical trials where the drug was administered as monotherapy for a short period. Moxifloxacin should be taken during the intensive (6 month) and continuation (12-18 months) phases of treatment.